GenapSys launches sequencer in Asia, lands new funding

By LabPulse.com staff writers

February 12, 2020 -- GenapSys has launched its gene sequencer in the Asia-Pacific region and garnered $75 million in financing to support its international expansion.

The firm said its gene sequencer is positioned to help researchers and public health officials across Asia better track and understand the coronavirus outbreak. The sequencer is less expensive and 100 times smaller than legacy high-throughput sequencers, and it can run off a standard power source, according to the vendor.

The international growth initiative will be supported by a $75 million financing deal from Oxford Finance, according to GenapSys. The company has already signed 25 distributorship deals worldwide with partners including Research Instruments of Singapore, Biomedical Systems of Korea, and Gene Company in Hong Kong. GenapSys said it's also interested in partnering with local health agencies and researchers.

Although it's currently focused on helping researchers and clinicians obtain access to its sequencer to combat pandemic outbreaks, the firm said the technology's benefits extend beyond infectious diseases to applications in cancer research, food science, personalized medicine, forensics, and other key scientific and medical fields.

Mobidiag, Autobio plan 30-minute coronavirus test
Mobidiag of Finland and Autobio Diagnostics of China are developing a rapid test for the novel coronavirus (2019-nCoV) and influenza viruses that they...
CMS offers guidance on use of CDC coronavirus test
The U.S. Centers for Medicare and Medicaid Services (CMS) on February 6 offered guidance to medical labs in the field on how to use a diagnostic test...
Wuhan coronavirus RT-PCR tests deliver results fast
Scientists in Hong Kong and China have developed rapid reverse transcription polymerase chain reaction (RT-PCR) tests that may be used to identify and...
Enrichment NGS emerges as surveillance tool for coronavirus
As the coronavirus continues to grow as a global health concern, researchers are urgently seeking efficient methods to predict and mitigate emerging coronavirus...
Laboratories, IVD vendors get to work on novel coronavirus
The emergence of novel viruses underscores the need for laboratories to be vigilant and for IVD vendors to constantly update test menus, writes Bruce...

Copyright © 2020 LabPulse.com

Last Updated np 2/11/2020 6:01:26 PM



Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.
Email
Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current